Discover Labs LLC

Discover Labs LLC was paid $9.05M by Medicaid between Nov 2020 and Dec 2024, across 13 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 87% of everything it billed.

33Billing provider infoDISCOVER LABS LLC
AUSTIN, TX 78750

33aNPI1417554098assigned 10/06/2020

33bProvider typeClinical Medical Laboratory

28Total paid$9.05M

24GClaims345,966

24DCodes billed13

24AFirst – last monthNov 2020 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#18 of 436

Median peer was paid$17K

This provider vs. median524×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,103	$46K
2021	85,957	$2.32M
2022	233,783	$6.04M
2023	24,527	$630K
2024incomplete	596	$2K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	87%	196,581	57,136	$7.90M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	132,217	39,875	$981K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	1.7%	13,113	6,143	$150K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,606	1,172	$11K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,035	367	$7K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	62	57	$626.40
87641		<1%	60	57	$192.04
87631		<1%	35	35	$119.81
87581		<1%	51	48	$109.79
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	50	47	$80.31
87541		<1%	51	48	$80.31
87640		<1%	54	51	$80.31

1 more codes

87486

<1%

$80.31

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROWLAND, JOHN (CHIEF OPERATING OFFICER)

Same official

Other billing entities under ROWLAND, JOHN

Full network →

Provider	Location	Paid
Coeur D'alene Tribe Physical Therapy, LLC	Plummer, ID	$20K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.